Literature DB >> 32619424

TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.

Leandro Venturutti1, Matt Teater1, Andrew Zhai2, Amy Chadburn3, Leena Babiker1, Daleum Kim1, Wendy Béguelin1, Tak C Lee1, Youngjun Kim4, Christopher R Chin5, William T Yewdell6, Brian Raught7, Jude M Phillip1, Yanwen Jiang1, Louis M Staudt8, Michael R Green9, Jayanta Chaudhuri10, Olivier Elemento11, Pedro Farinha12, Andrew P Weng13, Michael D Nissen14, Christian Steidl12, Ryan D Morin12, David W Scott12, Gilbert G Privé15, Ari M Melnick16.   

Abstract

The most aggressive B cell lymphomas frequently manifest extranodal distribution and carry somatic mutations in the poorly characterized gene TBL1XR1. Here, we show that TBL1XR1 mutations skew the humoral immune response toward generating abnormal immature memory B cells (MB), while impairing plasma cell differentiation. At the molecular level, TBL1XR1 mutants co-opt SMRT/HDAC3 repressor complexes toward binding the MB cell transcription factor (TF) BACH2 at the expense of the germinal center (GC) TF BCL6, leading to pre-memory transcriptional reprogramming and cell-fate bias. Upon antigen recall, TBL1XR1 mutant MB cells fail to differentiate into plasma cells and instead preferentially reenter new GC reactions, providing evidence for a cyclic reentry lymphomagenesis mechanism. Ultimately, TBL1XR1 alterations lead to a striking extranodal immunoblastic lymphoma phenotype that mimics the human disease. Both human and murine lymphomas feature expanded MB-like cell populations, consistent with a MB-cell origin and delineating an unforeseen pathway for malignant transformation of the immune system.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABC-DLBCL; BACH2; BCL6; TBL1XR1; cell fate; cell of origin; extranodal lymphoma; germinal center; memory B cells

Mesh:

Substances:

Year:  2020        PMID: 32619424      PMCID: PMC7384961          DOI: 10.1016/j.cell.2020.05.049

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  116 in total

1.  Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells.

Authors:  Chance John Luckey; Deepta Bhattacharya; Ananda W Goldrath; Irving L Weissman; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

2.  T Follicular Helper Cell-Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate.

Authors:  Wataru Ise; Kentaro Fujii; Katsuyuki Shiroguchi; Ayako Ito; Kohei Kometani; Kiyoshi Takeda; Eiryo Kawakami; Kazuo Yamashita; Kazuhiro Suzuki; Takaharu Okada; Tomohiro Kurosaki
Journal:  Immunity       Date:  2018-04-17       Impact factor: 31.745

3.  Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.

Authors:  Giorgio Cattoretti; Laura Pasqualucci; Gianna Ballon; Wayne Tam; Subhadra V Nandula; Qiong Shen; Tongwei Mo; Vundavalli V Murty; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

4.  EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.

Authors:  Wendy Béguelin; Relja Popovic; Matt Teater; Yanwen Jiang; Karen L Bunting; Monica Rosen; Hao Shen; Shao Ning Yang; Ling Wang; Teresa Ezponda; Eva Martinez-Garcia; Haikuo Zhang; Yupeng Zheng; Sharad K Verma; Michael T McCabe; Heidi M Ott; Glenn S Van Aller; Ryan G Kruger; Yan Liu; Charles F McHugh; David W Scott; Young Rock Chung; Neil Kelleher; Rita Shaknovich; Caretha L Creasy; Randy D Gascoyne; Kwok-Kin Wong; Leandro Cerchietti; Ross L Levine; Omar Abdel-Wahab; Jonathan D Licht; Olivier Elemento; Ari M Melnick
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

5.  Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation.

Authors:  Martina Minnich; Hiromi Tagoh; Peter Bönelt; Elin Axelsson; Maria Fischer; Beatriz Cebolla; Alexander Tarakhovsky; Stephen L Nutt; Markus Jaritz; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2016-01-18       Impact factor: 25.606

6.  Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.

Authors:  Bjoern Chapuy; Chip Stewart; Andrew J Dunford; Jaegil Kim; Atanas Kamburov; Robert A Redd; Mike S Lawrence; Margaretha G M Roemer; Amy J Li; Marita Ziepert; Annette M Staiger; Jeremiah A Wala; Matthew D Ducar; Ignaty Leshchiner; Ester Rheinbay; Amaro Taylor-Weiner; Caroline A Coughlin; Julian M Hess; Chandra S Pedamallu; Dimitri Livitz; Daniel Rosebrock; Mara Rosenberg; Adam A Tracy; Heike Horn; Paul van Hummelen; Andrew L Feldman; Brian K Link; Anne J Novak; James R Cerhan; Thomas M Habermann; Reiner Siebert; Andreas Rosenwald; Aaron R Thorner; Matthew L Meyerson; Todd R Golub; Rameen Beroukhim; Gerald G Wulf; German Ott; Scott J Rodig; Stefano Monti; Donna S Neuberg; Markus Loeffler; Michael Pfreundschuh; Lorenz Trümper; Gad Getz; Margaret A Shipp
Journal:  Nat Med       Date:  2018-04-30       Impact factor: 53.440

7.  Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation.

Authors:  Chuanxin Huang; Huimin Geng; Isaac Boss; Ling Wang; Ari Melnick
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

Review 8.  Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay.

Authors:  Raghava Kashyap; Bhagwant Rai Mittal; Kuruva Manohar; Chidambaram Natrajan Balasubramanian Harisankar; Anish Bhattacharya; Baljinder Singh; Pankaj Malhotra; Subhash Varma
Journal:  Cancer Imaging       Date:  2011-11-26       Impact factor: 3.909

9.  The CRAPome: a contaminant repository for affinity purification-mass spectrometry data.

Authors:  Dattatreya Mellacheruvu; Zachary Wright; Amber L Couzens; Jean-Philippe Lambert; Nicole A St-Denis; Tuo Li; Yana V Miteva; Simon Hauri; Mihaela E Sardiu; Teck Yew Low; Vincentius A Halim; Richard D Bagshaw; Nina C Hubner; Abdallah Al-Hakim; Annie Bouchard; Denis Faubert; Damian Fermin; Wade H Dunham; Marilyn Goudreault; Zhen-Yuan Lin; Beatriz Gonzalez Badillo; Tony Pawson; Daniel Durocher; Benoit Coulombe; Ruedi Aebersold; Giulio Superti-Furga; Jacques Colinge; Albert J R Heck; Hyungwon Choi; Matthias Gstaiger; Shabaz Mohammed; Ileana M Cristea; Keiryn L Bennett; Mike P Washburn; Brian Raught; Rob M Ewing; Anne-Claude Gingras; Alexey I Nesvizhskii
Journal:  Nat Methods       Date:  2013-07-07       Impact factor: 28.547

10.  A specific mutation in TBL1XR1 causes Pierpont syndrome.

Authors:  Charlotte A Heinen; Aldo Jongejan; Peter J Watson; Bert Redeker; Anita Boelen; Olga Boudzovitch-Surovtseva; Francesca Forzano; Roel Hordijk; Richard Kelley; Ann H Olney; Mary Ella Pierpont; G Bradley Schaefer; Fiona Stewart; A S Paul van Trotsenburg; Eric Fliers; John W R Schwabe; Raoul C Hennekam
Journal:  J Med Genet       Date:  2016-01-14       Impact factor: 6.318

View more
  15 in total

1.  The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications.

Authors:  Diana Giannuzzi; Laura Marconato; Antonella Fanelli; Luca Licenziato; Raffaella De Maria; Andrea Rinaldi; Luca Rotta; Nicole Rouquet; Giovanni Birolo; Piero Fariselli; Afua A Mensah; Francesco Bertoni; Luca Aresu
Journal:  Lab Anim (NY)       Date:  2022-06-20       Impact factor: 12.625

2.  Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.

Authors:  Wyndham H Wilson; George W Wright; Da Wei Huang; Brendan Hodkinson; Sriram Balasubramanian; Yue Fan; Jessica Vermeulen; Martin Shreeve; Louis M Staudt
Journal:  Cancer Cell       Date:  2021-11-04       Impact factor: 31.743

3.  Diverging regulation of Bach2 protein and RNA expression determine cell fate in early B cell response.

Authors:  Qianwen Hu; Tingting Xu; Min Zhang; Heng Zhang; Yongbo Liu; Hua-Bing Li; Chiqi Chen; Junke Zheng; Zhen Zhang; Fubin Li; Nan Shen; Wenqian Zhang; Ari Melnick; Chuanxin Huang
Journal:  Cell Rep       Date:  2022-07-05       Impact factor: 9.995

4.  Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma.

Authors:  Xiao-Bo Wu; Shu-Ling Hou; Qiao-Hua Zhang; Ning Jia; Min Hou; Wen Shui
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

Review 5.  Mouse Models of Germinal Center Derived B-Cell Lymphomas.

Authors:  Stefanie N Meyer; Sanjay Koul; Laura Pasqualucci
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

6.  The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs.

Authors:  Leandro Venturutti; Ari M Melnick
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

7.  Harnessing lymphoma epigenetics to improve therapies.

Authors:  Haopeng Yang; Michael R Green
Journal:  Blood       Date:  2020-11-18       Impact factor: 22.113

8.  Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.

Authors:  Bryan Rea; Yen-Chun Liu; Alanna Maguire; Lorinda A Soma; Chris M Bacon; Michael G Bayerl; Molly H Smith; Michael T Barrett; Steven H Swerdlow; Sarah E Gibson
Journal:  Mod Pathol       Date:  2021-12-24       Impact factor: 8.209

Review 9.  Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.

Authors:  Noushin Mossadegh-Keller; Gabriel Brisou; Alicia Beyou; Bertrand Nadel; Sandrine Roulland
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

Review 10.  Transcriptional regulation of memory B cell differentiation.

Authors:  Brian J Laidlaw; Jason G Cyster
Journal:  Nat Rev Immunol       Date:  2020-10-06       Impact factor: 108.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.